Resignation letter states: “truth and transparency” around vaccines are not desired by Health Secretary RJK Jr.

An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.

Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D.

Thoughts on the US National Institutes of Health and its role in funding research for non-opioid therapeutics.

With competition for skilled employees in cell and gene therapy manufacturing high, companies need to invest in training and mentorship.

Michiel van den Berg sheds light on the challenges and opportunities facing the industry as it adapts to new materials and regulatory requirements

FDA letter sent to Edenbridge Pharmaceuticals demonstrates the challenges of getting pharma advertising right.

Neal Baer, editor of a collection of essays on CRISPR, says we must not overlook the dark side of the technology.

How hot melt extrusion can enhance drug solubility and bioavailability, offering advantages over spray drying for oral dosage form development.

The role of digital technologies in optimizing traceability in pharmaceutical supply chains.